Observational Study of Neuromuscular Function in CMT Type 1&2 and Healthy Controls
Completed
Conditions studied: Charcot-Marie-Tooth Disease
In brief
The primary aim of this study is to discover whether patients with CMT type 1 and 2 have neuromuscular junction transmission deficits. The secondary aim is to collect information of different clinical and electrophysiological test procedures to perform possible future clinical trials in CMT patients.
Key facts
- Study ID
- NCT04980807
- Run by
- NMD Pharma A/S
- People needed
- 30
- Starts
- 2021-04-07
- Expected to finish
- 2022-03-03
- Last updated by the study team
- 2022-03-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Ohio State University — Columbus, Ohio, United States
- Aarhus University Hospital — Aarhus, Jutland, Denmark
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.